Brain Stimulation + Physical Therapy for Parkinson's Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether combining brain stimulation techniques—transcranial direct current stimulation (tDCS) and transcranial ultrasound (TUS)—with physical therapy can improve balance and posture in people with Parkinson's disease. The study is double-blinded and placebo-controlled, meaning some participants receive a placebo to compare results. It suits those with Parkinson's who experience balance issues and have been on stable medication for at least a month. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance the quality of life for Parkinson's patients.
Will I have to stop taking my current medications?
The trial requires that participants have been taking stable medications for Parkinson's disease for at least 30 days, so you will not need to stop your current medications.
What prior data suggests that this brain stimulation technique is safe for Parkinson's disease patients?
Research has shown that both transcranial direct current stimulation (tDCS) and transcranial ultrasound stimulation (TUS) are generally safe. TUS uses sound waves to stimulate the brain and is a non-invasive method with a strong safety record, often used in studies for neurological diseases like Parkinson's.
Similarly, physical therapy (PT) is considered safe for people with Parkinson's disease. Exercise plays a crucial role in managing Parkinson's and has improved symptoms without major safety concerns.
Overall, previous studies suggest that these treatments are well-tolerated when used together. While the specific combination of tDCS and TUS in this trial remains under study, each treatment has demonstrated positive safety results individually.12345Why are researchers excited about this trial?
Researchers are excited about combining brain stimulation techniques with physical therapy for Parkinson's Disease because it offers a fresh approach compared to traditional medications like Levodopa and dopamine agonists. The study uses two innovative brain stimulation methods: transcranial Direct Current Stimulation (tDCS) and transcranial Ultrasound Stimulation (TUS). These techniques aim to improve brain function and motor skills by directly influencing neural activity, which is different from how typical medications work. This combination could potentially enhance physical therapy outcomes and improve quality of life for individuals with Parkinson's.
What evidence suggests that this trial's treatments could be effective for postural instability in Parkinson's disease?
Research suggests that transcranial direct current stimulation (tDCS) might help treat Parkinson's disease. Some studies have found that tDCS can improve walking and balance, common issues for people with Parkinson's. However, not all studies agree, as some have not shown significant improvements. Researchers are also studying transcranial ultrasound stimulation (TUS), but more research is needed to understand its effects. In this trial, participants will receive either active tDCS and active TUS or sham tDCS and sham TUS. Combining tDCS and TUS with physical therapy might lead to better results, as each method offers unique benefits. Overall, this combination is believed to help with balance issues in Parkinson's patients, but more evidence is needed.678910
Who Is on the Research Team?
Felipe Fregni, MD, PhD, MPH
Principal Investigator
Spaulding Rehabilitation Hospital
Are You a Good Fit for This Trial?
This trial is for people aged 40-90 with Parkinson's Disease who have balance issues or postural instability and are on stable PD medications. Excluded are those with other balance-affecting conditions, brain surgeries, metal in the head, severe medical problems, pregnancy, recent PT programs, non-PD parkinsonism syndromes, certain psychiatric or substance abuse histories.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment Phase I
Participants receive tDCS+TUS combined with physical therapy for 2 weeks
Treatment Phase II
Biweekly sessions of tDCS+TUS combined with physical therapy for an additional 2 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Active tDCS and Active TUS
- Physical Therapy
- Sham TDCS and Sham TUS
Find a Clinic Near You
Who Is Running the Clinical Trial?
Spaulding Rehabilitation Hospital
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Highland Instruments, Inc.
Industry Sponsor